| |
Darryl L. Goss joins Bioreliance
Darryl L. Goss has been appointed Vice
President, Toxicology/Laboratory Animal Diagnostic Services (LADS), a new executive position created to lead this newly
formed Business Unit.
Click here to read the
press release.
|
|
|
|
|
The use of animal models to determine the toxicity of a pharmaceutical, biopharmaceutical or medical device is a required part of evaluating the overall safety of the product and predicting its effects on humans.
|
Back to Mammalian Toxicology
BioReliance is internationally recognized for our experience in the successful management and performance of multidisciplinary biomedical and toxicological research projects that draw scientific expertise from a variety of disciplines. Specialty studies include enzyme induction studies, tumor initiation and promotion studies.
Assays offered by BioReliance:
| Evaluation of Tumor Formation |
2S82 |
| Bioassay for Initiating or Promoting Activity |
7D82 |
|
 |
|
|
